Laurion Capital Management LP Zymeworks Inc. Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.82 - $7.7 $578,400 - $924,000	-120,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.0 - $16.98 $720,000 - $2.04 Million	120,000 New	120,000 $786,000
Q4 2018 Feb 14, 2019	SELL	$10.95 - $15.44 $131,750 - $185,774	-12,032 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$12.21 - $16.61 $1.18 Million - $1.61 Million	-97,043 Reduced 88.97%	12,032 $189,000
Q2 2018 Aug 13, 2018	BUY	$11.13 - $21.86 $1.21 Million - $2.38 Million	109,075 New	109,075 $1.61 Million

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $926M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.